Article
IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma.
Medical science monitor : international medical journal of experimental and clinical research - 14 Feb 2014
Lu Jun, Xu Ling, Zou Yang, Yang Run-Xiang, Fan Yu, Zhang Wen, Yu Dandan, Yao Yong-Gang
Abstract excerpt
BACKGROUND: Recent studies have identified prevalent isocitrate dehydrogenase 1 (IDH1) codon 132 mutations (p.R132) in gliomas and acute myeloid leukemia (AML). The IDH1 mutations lead to a loss of its normal enzymatic activity and acquisition of neomorphic activity in production of alpha-ketoglutarate (alpha-KG) and 2-hydroxyglutarate (2-HG), which finally cause alterations of multiple gene expression of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
